Individuals with defects in copper metabolism may soon have more targeted treatment options thanks to a new discovery. A new report that an investigational anticancer-drug, elesclomol, can restore the production of cytochrome oxidase protein complex, a critical copper-dependent enzyme required for mitochondrial energy production.
from Top Health News -- ScienceDaily https://ift.tt/2v59Kzs
the news of the day, for today, top news of today, world news today live, top local news, top news stories of the day, top news today in the world, news today nyc, top news today local,
Subscribe to:
Post Comments (Atom)
After 30 years, scientists finally have a drug for a deadly brain disease
The FDA has approved the first drug that directly targets Alexander disease, a devastating neurological disorder affecting fewer than one in...
-
from Yahoo News - Latest News & Headlines https://ift.tt/3F3zLk8
-
from Yahoo News - Latest News & Headlines https://ift.tt/VDTlZbk
-
Two of the traits that set modern humans apart from non-human primates are taller stature and a higher basal metabolic rate. Researchers hav...
No comments:
Post a Comment